Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Receivables (2016 - 2025)

Historic Change in Receivables for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $76755.0.

  • cbdMD's Change in Receivables fell 7343.53% to $76755.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $227384.0, marking a year-over-year increase of 2756.68%. This contributed to the annual value of $439565.0 for FY2025, which is 34714.38% up from last year.
  • cbdMD's Change in Receivables amounted to $76755.0 in Q4 2025, which was down 7343.53% from $456916.0 recorded in Q3 2025.
  • In the past 5 years, cbdMD's Change in Receivables registered a high of $1.0 million during Q1 2021, and its lowest value of -$815369.0 during Q2 2022.
  • In the last 5 years, cbdMD's Change in Receivables had a median value of -$27183.5 in 2021 and averaged $14412.3.
  • As far as peak fluctuations go, cbdMD's Change in Receivables soared by 1354446.58% in 2021, and later plummeted by 1195777.34% in 2022.
  • Over the past 5 years, cbdMD's Change in Receivables (Quarter) stood at -$4554.0 in 2021, then crashed by 11957.77% to -$549111.0 in 2022, then skyrocketed by 87.77% to -$67169.0 in 2023, then soared by 530.16% to $288936.0 in 2024, then plummeted by 73.44% to $76755.0 in 2025.
  • Its Change in Receivables stands at $76755.0 for Q4 2025, versus $456916.0 for Q3 2025 and -$84759.0 for Q2 2025.